Stewart Jeffrey Ryan's Form 4 filing
AbbVie Inc. (ABBV) · filed Dec 17, 2021
- Accession no.
- 0001179110-21-011109
- Filed
- Dec 17, 2021
- Trade date
- Dec 15, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $275.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stewart Jeffrey RyanCIK 0001761675 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | Common Stock, $0.01 par value | SSaleDisposed | −2,152 | $128.00 | −$275,456 | 47,104 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).